EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations

Camille Rothenberg-Lausell, Jonathan Bar, Dante Dahabreh, Yael Renert-Yuval, Ester Del Duca, Emma Guttman-Yassky

Journal of Allergy and Clinical Immunology · 2024-07 · 154 (1) · 20-30

DOI: 10.1016/j.jaci.2024.04.009 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2024-07. Verfasst von Camille Rothenberg-Lausell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; University of Puerto R…. Hauptthemen laut MEDLINE: Dermatitis, Atopic. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 146 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a complex and heterogeneous skin disease for which achieving complete clinical clearance for most patients has proven challenging through single cytokine inhibition. Current studies integrate biomarkers and evaluate their role in AD, aiming to advance our understanding of the diverse molecular profiles implicated. Although traditionally characterized as a TH2-driven disease, extensive research has recently revealed the involvement of TH1, TH17, and TH22 immune pathways as well as the interplay of pivotal immune molecules, such as OX40, OX40 ligand (OX40L), thymic stromal lymphopoietin, and IL-33. This review explores the mechanistic effects of treatments for AD, focusing on mAbs and Janus kinase inhibitors. It describes how these treatments modulate immune pathways and examines their impact on key inflammatory and barrier biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, AtopicHumansCytokinesJanus Kinase InhibitorsAntibodies, MonoclonalAnimals

Stichwörter der Autor:innen

Atopic dermatitisJAK inhibitorsbiologicsmolecular biomarkerssmall-molecule antagoniststargeted treatment

Substanzen

CytokinesJanus Kinase InhibitorsAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; University of Puerto Rico School of Medicine, San Juan, Puerto Rico.
  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY.
  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; Pediatric Dermatology Unit, Schneider Children's Medical Center of Israel and the Faculty of…
  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; Department of Dermatology, University of La Sapienza, Rome, Italy.
  • Department of Dermatology and Laboratory of Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Emma.Guttman@mountsinai.org.

Zitieren

APA

Rothenberg-Lausell, C., Bar, J., Dahabreh, D., Renert-Yuval, Y., Del Duca, E., & Guttman-Yassky, E. (2024). Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations. Journal of Allergy and Clinical Immunology, 154(1), 20-30. https://doi.org/10.1016/j.jaci.2024.04.009

Vancouver

Rothenberg-Lausell C, Bar J, Dahabreh D, Renert-Yuval Y, Del Duca E, Guttman-Yassky E. Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations. Journal of Allergy and Clinical Immunology. 2024;154(1):20-30. doi:10.1016/j.jaci.2024.04.009

BibTeX
@article{RothenbergLausell2024,
  author = {Rothenberg-Lausell, Camille and Bar, Jonathan and Dahabreh, Dante and Renert-Yuval, Yael and Del Duca, Ester and Guttman-Yassky, Emma},
  title = {Biologic and small-molecule therapy for treating moderate to severe atopic dermatitis: Mechanistic considerations},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2024},
  volume = {154},
  number = {1},
  pages = {20--30},
  doi = {10.1016/j.jaci.2024.04.009}
}
Kostenlos starten →